Background:
Our latest study reported the grim status of hypertension in rural China with the prevalence of hypertension reached 51.1%. However, we lack the latest data about the prevalence and epidemiological features of dyslipidemia among hypertensive residents in rural China.
Methods:
A cross-sectional survey was conducted from July 2012 to August 2013 through a cluster multistage sampling to a resident group of 4048 individuals (2152 men, 2896 women) with hypertension, age ≥ 35 years, in the rural Northeast China. Serum lipids level were proposed by National Cholesterol Education Program Adult Treatment Panel III.
Results:
Of the hypertension residents without antihypertension treatment, 34.5% had borderline high total cholesterol, 19.2% had high total cholesterol, 11.4% had low high-density lipoprotein cholesterol and 37.4% had high non HDL-C. The population with borderline high, high, and very high low-density lipoprotein cholesterol was 20.9, 6.7 and 2.3%, respectively. In addition, 14.3% had borderline high triglycerides, 17.4% had high TG and 2.4% had very high TG. The awareness rate of dyslipidemia among the study population was 5.9%. After adjusting for independent variables, fasting plasma glucose, body mass index, Han nationality, current drinking and smoking, higher annual income and classification of blood pressure were risk factors for dyslipidemia while moderate physical activity was protective factor for dyslipidemia. On the contrary, gender and current drinking decrease the risk of HDL-C.
Conclusion:
The prevalence of dyslipidemia was dramatically high and dyslipidemia screening was in-need in all diagnosed hypertensive individuals.
Citing Articles
The Effect of Nattokinase-Monascus Supplements on Dyslipidemia: A Four-Month Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Liu X, Zeng X, Mahe J, Guo K, He P, Yang Q
Nutrients. 2023; 15(19).
PMID: 37836525
PMC: 10574353.
DOI: 10.3390/nu15194239.
Evaluation of levels of uric acid and lipid profile in hospitalized patients with diabetes.
Fayazi H, Mortazavi Khatibani S, Motamed B, Yaseri M
BMC Res Notes. 2023; 16(1):154.
PMID: 37488643
PMC: 10367241.
DOI: 10.1186/s13104-023-06429-5.
Prevalence of dyslipidemia and associated risk factors among newly diagnosed Type-2 Diabetes Mellitus (T2DM) patients in Kushtia, Bangladesh.
Ahmmed M, Shuvo S, Paul D, Karim M, Kamruzzaman M, Mahmud N
PLOS Glob Public Health. 2023; 1(12):e0000003.
PMID: 36962092
PMC: 10021199.
DOI: 10.1371/journal.pgph.0000003.
Characteristics of serum lipid levels in patients with hypertension: a hospital-based retrospective descriptive study.
Wu H, Yu Z, Huang Q
BMJ Open. 2022; 12(6):e054682.
PMID: 36547874
PMC: 9171285.
DOI: 10.1136/bmjopen-2021-054682.
Association of microalbuminuria with serum lipids and inflammatory markers in an adult population in the Dikgale Health and Demographic Surveillance System site, South Africa.
Magwai T, Modjadji P, Choma S
Cardiovasc J Afr. 2022; 33(5):234-242.
PMID: 35687086
PMC: 9887442.
DOI: 10.5830/CVJA-2021-055.
Assessing the effect of socioeconomic factors on prevalence of dyslipidemia among iranian adult population; district level analysis from 2016 STEPS national study using small area estimation.
Soleimani H, Ghasemi E, Moghaddam S, Azadnajafabad S, Rezaei N, Masinaei M
J Diabetes Metab Disord. 2022; 21(1):647-655.
PMID: 35673466
PMC: 9167271.
DOI: 10.1007/s40200-022-01027-x.
Prevalence, patterns and determinants of dyslipidaemia among South African adults with comorbidities.
Masilela C, Adeniyi O, Benjeddou M
Sci Rep. 2022; 12(1):337.
PMID: 35013433
PMC: 8748924.
DOI: 10.1038/s41598-021-04150-6.
Usefulness of metabolic score for insulin resistance index in estimating the risk of mildly reduced estimate glomerular filtration rate: a cross-sectional study of rural population in China.
Wang P, Li Q, Guo X, Zhou Y, Li Z, Yang H
BMJ Open. 2021; 11(12):e050907.
PMID: 34916312
PMC: 8679137.
DOI: 10.1136/bmjopen-2021-050907.
Prevalence and predictors of dyslipidemia among hypertensive patients in Lumame Primary Hospital, Amhara, Ethiopia: A cross-sectional study.
Kifle Z, Alehegn A, Adugna M, Bayleyegn B
Metabol Open. 2021; 11:100108.
PMID: 34355158
PMC: 8319795.
DOI: 10.1016/j.metop.2021.100108.
Attenuating the Variability of Lipids Is Beneficial for the Hypertension Management to Reduce the Cardiovascular Morbidity and Mortality in Older Adults.
Dong Y, Liu X, Zhao Y, Chai Q, Zhang H, Gao Y
Front Cardiovasc Med. 2021; 8:692773.
PMID: 34222383
PMC: 8245783.
DOI: 10.3389/fcvm.2021.692773.
Prevalence and Associated Factors of Dyslipidemia Among Adults with Type 2 Diabetes Mellitus in Saudi Arabia.
Alzaheb R, Altemani A
Diabetes Metab Syndr Obes. 2020; 13:4033-4040.
PMID: 33149642
PMC: 7604430.
DOI: 10.2147/DMSO.S246068.
Traditional Chinese Patent Medicine for Primary Hypertension: A Bayesian Network Meta-Analysis.
Chen Z, Shi Q, Tan L, Peng Y, Liu C, Zhang J
Evid Based Complement Alternat Med. 2020; 2020:6701272.
PMID: 32382302
PMC: 7196995.
DOI: 10.1155/2020/6701272.
Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP).
Opoku S, Gan Y, Fu W, Chen D, Addo-Yobo E, Trofimovitch D
BMC Public Health. 2019; 19(1):1500.
PMID: 31711454
PMC: 6849283.
DOI: 10.1186/s12889-019-7827-5.
Dynamic development of metabolic syndrome and its risk prediction in Chinese population: a longitudinal study using Markov model.
Jia X, Chen Q, Wu P, Liu M, Chen X, Xiao J
Diabetol Metab Syndr. 2018; 10:24.
PMID: 29619091
PMC: 5880005.
DOI: 10.1186/s13098-018-0328-3.
